Yeying Huang

Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma

M. Schaller, C. French, U. Lauer, 2022, Cancers.

Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment

David A. Scott, Kristen L Jones, M. Kuroda, 2021, Molecular Cancer Research.

Exceptional Response to Bromodomain and Extraterminal Domain Inhibitor Therapy With BMS-986158 in BRD4-NUTM1 NUT Carcinoma Harboring a BRD4 Splice Site Mutation.

P. Jänne, L. Chirieac, J. LoPiccolo, 2023, JCO precision oncology.

Purge of malignant cells from bone marrow by hematoporphyrin derivatives and light exposurein vitro

Yeying Huang, Chengxiong Xu, Hong-Yue Liu, 1990, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes

C. Zahnow, J. Kutok, D. Root, 2023, bioRxiv.